Access
To read this story in full you will need to login or make a payment (see right).
Insight
Nature 436, 967-972 (18 August 2005) | doi:10.1038/nature04082; Published online 17 August 2005
Open Innovation Challenges
- More Challenges
- Powered by:
nature jobs
Organic Chemistry
- Praj Matrix - Praj Industries Ltd
- Pune, Maharashtra Pune-411021 India
Gastrointestinal Pathologist
- Brigham and Women's Hospital
- Boston, MA
review article Mechanism of action of interferon and ribavirin in treatment of hepatitis C
Jordan J. Feld1 & Jay H. Hoofnagle2
Abstract
Since the identification of the hepatitis C virus, great strides have been made in the development of an antiviral therapy. As a crucial mediator of the innate antiviral immune response, interferon-
(IFN-) was a natural choice for treatment. Whereas treatment with IFN- alone achieved only modest success, the addition of the broad-spectrum antiviral agent ribavirin greatly improved responses. However, half of the infected individuals with chronic disease do not achieve sustained clearance of hepatitis C virus. To optimize current therapeutic strategies and to develop new therapies, a better understanding of the mechanism of action of IFN and ribavirin will be essential.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Hepatitis C New therapeutic strategies needed for advanced diseaseNature Reviews Gastroenterology & Hepatology News and Views (01 Jun 2009)
Interferon-alfa, interferon-λ and hepatitis CNature Genetics News and Views (01 Oct 2009)
See all 4 matches for News And Views